Pluripotent patents make prime time: an analysis of the emerging landscape

Journal name:
Nature Biotechnology
Volume:
28,
Pages:
557–559
Year published:
DOI:
doi:10.1038/nbt0610-557
Corrected online

An examination of three patents in the fast-moving iPS space may help determine their ultimate value.

Change history

Corrected online 13 October 2010
In the version of this article initially published, the authors state: “The patents have been cross-licensed, protecting against unlicensed use of either method. Both the Sakurada and Yamanaka patents are part of the portfolio held by iPierian, a company recently formed by the merger of iZumi Bio, a San Francisco Bay Area biotech and Boston-based Pierian.” This statement is incorrect. The Yamanaka patent (owned by Kyoto University) is not licensed to iPierian. The Sakurada patent (owned by iPierian) is not licensed to Kyoto University. The error has been corrected in the HTML and PDF versions of the article.

References

  1. Takahashi, K. et al. Cell 131, 861872 (2007).
  2. Yu, J. et al. Science 318, 19171920 (2007).
  3. Park, I. et al. Cell 134, 877886 (2008).
  4. Yamanaka, S. Japan patent JP 2008131577 (2008).
  5. Sakurada, K. et al. UK patent GB2450603 (2010).
  6. Jaenisch, R. et al. US patent 7,682,828 (20104).
  7. 35 USC § 112.
  8. Ariad Pharms., Inc. v. Eli Lilly & Co., 598 F.3d 1366 (Fed. Cir. 2010) (en banc).
  9. In re Wands, 858 F.2d 731 (Fed. Cir. 1988).
  10. Regents of the University of California v. Eli Lilly & Co., 119 F.3d 1559 (Fed. Cir. 1997).
  11. USPTO. Manual of Patent Examining Procedure §§ 2131.02, 2144.08, edn. 8th (US Patent and Trademark Office; 2008).
  12. Evans, M.J. & Kaufman, M.H. Nature 292, 154156 (1981).
  13. Vrtovec, K. & Scott, C.T. Nat. Biotechnol. 26, 393395 (2008).
  14. USPTO Board of Patent Appeals and Interferences, Foundation of Taxpayer & Consumer Rights v. Patent of WARF, Appeal 2010-001854, Patent 7,029,913 (April 28, 2010).
  15. Jaenisch, R. et al. United States Patent Application No. 12/703,061 (filed 2010).
  16. Jaenisch, R. et al. United States Patent Application No. 12/703,015 (filed 2010).
  17. USPTO Requirement for Restriction/Election in US Patent Application No. 10/997,146 (mailed May 24, 2006).
  18. Yu, J. & Thomson, J.A. Genes Dev. 22, 19871997 (2008).
  19. In re Kubin, 561 F.3d 1351 (Fed. Cir. 2009).
  20. Zhou, H. et al. Cell Stem Cell 4, 381384 (2009).
  21. Normile, D. Science Insider (February 8, 2010). http://news.sciencemag.org/scienceinsider/2010/02/landmark-plurip.html

Download references

Author information

Affiliations

  1. Brenda M. Simon and Charles E. Murdoch are at the Stanford University Center for Law and the Biosciences Stanford, California, USA.

    • Christopher T Scott
  2. Charles E. Murdoch and Christopher T. Scott are at the Stanford University Program on Stem Cells in Society, Stanford, California, USA.

Competing financial interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to:

Author details

Additional data